1 / 12

Preventing ARIs with Vaccines

Preventing ARIs with Vaccines. ARIAtlas.org. Most of the world still lacks the pneumococcal vaccine. Source: ARIAtlas.org , World Lung Foundation 2010. Pneumococcal death rates are much higher where the vaccine is unavailable. Source: ARIAtlas.org , World Lung Foundation 2010.

sheng
Télécharger la présentation

Preventing ARIs with Vaccines

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Preventing ARIs with Vaccines ARIAtlas.org

  2. Most of the world still lacks the pneumococcal vaccine. Source: ARIAtlas.org, World Lung Foundation 2010

  3. Pneumococcal death rates are much higher where the vaccine is unavailable. Source: ARIAtlas.org, World Lung Foundation 2010

  4. Global Impact • Ninety-three percent of the world’s children—121 million people—had not received a pneumococcal vaccine, and 71 percent, or 93 million children, had not received the Hib vaccine, as of 2008. • The burden of vaccine-preventable diseases, which are responsible for one-quarter of global childhood deaths every year, falls on the poor. In low-income countries, pneumonia kills 7,320 out of 100,000 children under age five, compared with just 34 children in high-income countries.

  5. Global Impact • AlleviA system to regulate vaccines, such as that overseen by the U.S. Food and Drug Administration, exists in all developed countries but in only one-quarter of developing countries, yet vaccine production increasingly occurs in Brazil, China, India, and other developing countries.

  6. The Hib vaccine has been widelyintroduced in 102 countries. Source: ARIAtlas.org, World Lung Foundation 2010

  7. Hib death rates are much higher in countries where the vaccine is unavailable. Source: ARIAtlas.org, World Lung Foundation 2010

  8. The Vaccine Gap:National income is a key influence on how quickly a vaccine is introduced. Rate of Cumulative Introduction Years after first introduction Source: ARIAtlas.org, World Lung Foundation 2010

  9. Actions That Make a Difference • More financial resources are needed to distribute vaccines. Despite significant donor commitments and innovative funding mechanisms, the Global Alliance on Vaccines and Immunisation does not have the resources to meet its 2015 goals for reducing the toll of vaccine-preventable diseases.

  10. Actions That Make a Difference • Immunizing more children and adults depends on a strong vaccine delivery infrastructure, effective leadership, national commitment, efforts to integrate immunization programs with other health care services, and engaged communities that understand the value of vaccines.

  11. Actions That Make a Difference • Efforts are needed to combat misunderstanding and lack of information about vaccines. In some developed countries, an antivaccine movement has been built on the discredited fear that vaccines are linked to autism. And in some developing countries, other fears hold sway: In one region of Nigeria, tribal peoples believe that vaccines are being used to sterilize their children and destroy the tribe.

  12. Actions That Make a Difference • New vaccines are needed to combat RSV and other acute respiratory infections. Research should also focus on improving the effectiveness of existing vaccines, reducing the required immunization dose, and developing all-in-one combinations.

More Related